Jerrell Shelton Sells 28,800 Shares of CryoPort (NASDAQ:CYRX) Stock

CryoPort, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton sold 28,800 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $14.91, for a total transaction of $429,408.00. Following the completion of the transaction, the chief executive officer directly owned 1,201,814 shares of the company’s stock, valued at approximately $17,919,046.74. The trade was a 2.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

CryoPort Price Performance

Shares of CryoPort stock opened at $14.80 on Thursday. CryoPort, Inc. has a 1-year low of $7.61 and a 1-year high of $16.89. The company has a market capitalization of $749.62 million, a PE ratio of -16.44 and a beta of 1.89. The business has a 50-day moving average of $15.42 and a 200-day moving average of $12.01.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings results on Thursday, August 6th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.01). The business had revenue of $48.97 million during the quarter, compared to analyst estimates of $48.18 million. CryoPort had a negative return on equity of 7.20% and a negative net margin of 20.05%. On average, equities analysts expect that CryoPort, Inc. will post -0.83 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on CYRX shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CryoPort in a research report on Monday, August 3rd. Roth Capital reissued a “buy” rating and set a $21.00 price target on shares of CryoPort in a research report on Friday, August 7th. Craig Hallum lifted their price target on shares of CryoPort from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, June 3rd. Wall Street Zen raised shares of CryoPort from a “sell” rating to a “hold” rating in a report on Monday, May 11th. Finally, KeyCorp increased their price objective on shares of CryoPort from $15.00 to $17.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $18.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CYRX. Basepoint Wealth LLC acquired a new stake in CryoPort in the fourth quarter worth $34,000. Tower Research Capital LLC TRC boosted its holdings in shares of CryoPort by 300.1% during the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after acquiring an additional 4,375 shares during the period. Creative Planning bought a new position in shares of CryoPort during the second quarter worth about $96,000. Quadrature Capital Ltd acquired a new stake in shares of CryoPort in the 4th quarter worth about $97,000. Finally, State of Wyoming increased its holdings in shares of CryoPort by 30.2% in the 2nd quarter. State of Wyoming now owns 14,218 shares of the company’s stock worth $106,000 after acquiring an additional 3,301 shares during the period. Institutional investors and hedge funds own 92.90% of the company’s stock.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.